Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Feature-Tracking Cardiac Magnetic Resonance Method: A Valuable Marker of Replacement Fibrosis in Hypertrophic Cardiomyopathy Publisher



Rezaeian N1 ; Hosseini L2 ; Omidi N3 ; Khaki M1 ; Najafi H1 ; Kasani K1 ; Mousavizadeh M1 ; Khalili Y1 ; Komasi MMH4 ; Toloueitabar Y1 ; Asadian S1
Authors

Source: Polish Journal of Radiology Published:2022


Abstract

Purpose: Left ventricular (LV) replacement fibrosis is a marker of adverse cardiac events in hypertrophic cardiomyo-pathy (HCM). We aimed to assess the efficacy of the feature-tracking cardiac magnetic resonance (FT-CMR) in the detection of LV replacement fibrosis. Material and methods: Fifty-one patients with HCM (51% female, mean age = 21 ± 5.2 years) and significant myocardial hypertrophy, who underwent CMR between February 2018 and December 2019 were enrolled. Functional and 3D FT-CMR parameters were measured. LV global longitudinal strain, global radial strain (GRS), and global circum-ferential strain (GCS) were recorded. The percentage of enhanced myocardial mass was calculated. Univariate and multivariate regression analyses were performed to determine the predictors of fibrosis. A p-value of less than 0.05 was considered significant. Results: The mean enhanced mass percentage was 15.2 ± 10.53%. Among LV volumetric parameters, end-systolic and end-diastolic volume indices predicted fibrosis (fitness [F] = 8.11 and p = 0.006 vs. F = 6.6 and p = 0.012, corre-spondingly). The univariate linear regression demonstrated that GCS and GRS predicted total enhanced mass (%) (F = 12.29 and p = 0.001 vs. F = 7.92 and p = 0.007, respectively). After the inclusion of all volumetric and deforma-tion parameters, the multivariate analysis identified the model of a combination of LV end-diastolic volume index (LV EDVI) and LV GCS as a robust predictor of the fibrosis percentage (F = 8.86 and p = 0.005). Conclusions: Non-contrast CMR parameters including LV GCS and LV EDVI are valuable markers of replacement fibrosis in HCM patients with notable myocardial hypertrophy. © Pol J Radiol 2022.
Other Related Docs
7. Role of Strain Imaging by Echocardiography in Pericardial Diseases; a Scoping Review, International Journal of Cardiovascular Imaging (2025)
9. Patient-Specific Study of Post-Ischemic Cardiac Ventricular Remodeling: A Passive Simulation of Structural Changes in Myofiber Orientation and Stiffness, 2022 29th National and 7th International Iranian Conference on Biomedical Engineering# ICBME 2022 (2022)
16. Predictors and Prognosis of End-Stage Hypertrophic Cardiomyopathy, International Cardiovascular Research Journal (2022)